12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga·12/22/2025 12:05:42
Listen to the news
Gainers
Abivax (NASDAQ:ABVX) stock rose 13.7% to $130.65 during Monday's pre-market session. The company's market cap stands at $8.9 billion.
Scinai Immunotherapeutics (NASDAQ:SCNI) stock increased by 11.27% to $0.88. The company's market cap stands at $2.7 million.
Edgewise Therapeutics (NASDAQ:EWTX) stock increased by 9.9% to $28.08. The company's market cap stands at $2.7 billion.
Equillium (NASDAQ:EQ) shares moved upwards by 9.56% to $1.26. The market value of their outstanding shares is at $70.0 million.
Tharimmune (NASDAQ:THAR) shares increased by 9.48% to $2.54. The market value of their outstanding shares is at $81.3 million.
Radiopharm Theranostics (NASDAQ:RADX) shares moved upwards by 8.86% to $5.65. The market value of their outstanding shares is at $40.3 million.
Losers
DBV Technologies (NASDAQ:DBVT) stock decreased by 8.6% to $20.8 during Monday's pre-market session. The market value of their outstanding shares is at $913.4 million.
Impact BioMedical (AMEX:IBO) stock declined by 7.55% to $0.6. The market value of their outstanding shares is at $7.9 million.
Intercure (NASDAQ:INCR) stock declined by 7.36% to $1.26. The market value of their outstanding shares is at $74.3 million.
BeyondSpring (NASDAQ:BYSI) shares fell 6.81% to $2.19. The market value of their outstanding shares is at $96.6 million.
Minerva Neurosciences (NASDAQ:NERV) shares fell 6.44% to $3.78. The company's market cap stands at $28.2 million.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure. Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.